Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome
Rachel M. Golonka, Matam Vijay‐Kumar
Advances in cancer research (2020), pp. 171-255
Closed Access | Times Cited: 22

Showing 22 citing articles:

Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Tengyue Hu, Changhai Liu, Min Lei, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 26
From chaos to order: optimizing fecal microbiota transplantation for enhanced immune checkpoint inhibitors efficacy
Anqi Lin, Aimin Jiang, Lihaoyun Huang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Beatrice Foglia, Marc Beltrà, Salvatore Sutti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7463-7463
Open Access | Times Cited: 31
Tumor microbiome metabolism: A game changer in cancer development and therapy
Xiaozhuang Zhou, Shruthi Kandalai, Farzana Hossain, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 33
Gut Microbiota Alteration Influences Colorectal Cancer Metastasis to the Liver by Remodeling the Liver Immune Microenvironment
Na Yuan, Xiaoyan Li, Meng Wang, et al.
Gut and Liver (2022) Vol. 16, Iss. 4, pp. 575-588
Open Access | Times Cited: 26
The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
Jiezhong Chen, Luis Vitetta, Jeremy D. Henson, et al.
Journal of Functional Foods (2021) Vol. 87, pp. 104850-104850
Open Access | Times Cited: 30
Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC
Haotian Qin, Weibei Sheng, Geng Zhang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 10
Factors of faecal microbiota transplantation applied to cancer management
Yi-Huang Liu, Juan Chen, Xiang Chen, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 2, pp. 101-114
Closed Access | Times Cited: 3
The Role of Metabolic Reprogramming in the Tumor Immune Microenvironment: Mechanisms and Opportunities for Immunotherapy in Hepatocellular Carcinoma
Nan Hu, Haiyang Li, Changcheng Tao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5584-5584
Open Access | Times Cited: 3
A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma
Hua Yang, Mu-Zi-he Zhang, Huiwei Sun, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer
Chenchen Bi, Geqiong Xiao, Chunyan Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 17
Revealing the Pathogenesis of Salt-Sensitive Hypertension in Dahl Salt-Sensitive Rats through Integrated Multi-Omics Analysis
Yanan Ouyang, Meng-di Yuan, Zheng-mao Yang, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1076-1076
Open Access | Times Cited: 10
Alcohol dehydrogenase 4 is a TP53‑associated gene signature for the prediction of prognosis in hepatocellular carcinoma
Yuan Zhang, Huihong Jiang, Zhenyu Wang, et al.
Oncology Letters (2022) Vol. 25, Iss. 1
Open Access | Times Cited: 9
Effect of Probiotics and Fecal Microbiota Transplantation in Dirty Rats with Established Primary Liver Cancer
Yanyan Cao, Lijie Zhang, Fu Xiong, et al.
Future Microbiology (2023) Vol. 19, Iss. 2, pp. 117-129
Closed Access | Times Cited: 5
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
Edda Russo, Camila Fiorindi, Francesco Giudici, et al.
World Journal of Hepatology (2022) Vol. 14, Iss. 2, pp. 372-385
Open Access | Times Cited: 8
Malignant liver tumors
Islam Mohamed, Ahmed El Sabagh, Fuad ZainAloor, et al.
Elsevier eBooks (2024), pp. 1181-1241
Closed Access
Gut Microbiome: Associations with Liver and Colon Cancer
Satya Priya Sharma, Ki Tae Suk
(2024), pp. 239-255
Closed Access
Gut Microbiota Alteration Influences Colorectal Cancer Metastasis to the Liver By Remodeling the Liver Immune Microenvironment
Na Yuan, Xiaoyan Li, Meng Wang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
ADH4 is a TP53-associated immunometabolic signature for prediction of prognosis in hepatocellular carcinoma
Moubin Lin, Yuan Zhang, Huihong Jiang, et al.
Research Square (Research Square) (2022)
Open Access
UGCG relieves iNKT cell-mediated liver injury by triggering endoplasmic reticulum stress in mice
Junfeng Li, Jian Gan, Xiaorong Mao, et al.
Research Square (Research Square) (2022)
Open Access
ADH4 Is A TP53-Associated Immune-Metabolic Signature For The Prediction Of Prognosis In Hepatocellular Carcinoma
Yuan Zhang, Huihong Jiang, Zhenyu Wang, et al.
Research Square (Research Square) (2022)
Closed Access
Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers
Aldona Kasprzak, Agnieszka Adamek
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11188-11188
Open Access
Page 1

Scroll to top